The American Diabetes Association guidelines do not list cognitive impairment as a common or expected adverse effect of metformin therapy
That means retatrutide activates GIP receptors at concentrations roughly twelve times lower than what it needs for GLP-1 activation
Plant-based alternatives like agar-agar will set the same way, but they don't provide protein, so you lose the potential fullness benefit
I've just had a lot of questions about it, so I wanted to do an episode about it
In conclusion, GLP-1 receptor agonists show potential in heart failure management through their multiple mechanisms of action, including direct cardioprotective effects, vasodilation, natriuresis, and glucose and weight control
Results Preliminary analyses (first measurement n=50